YTHDF1 and hepatocellular carcinoma: More and more evidence supports that YTHDF1 acts as an oncogene by affecting signaling pathways in cancers, including HCC [84], breast cancer [85], NSCLC [86], CRC [87], and Merkel cell carcinoma [88].